Across India, a silent epidemic is writing itself into insurance ledgers: liver disease claims have doubled in three years, tracing the quiet devastation of viral hepatitis in a population of 35 million carriers who often feel nothing until the damage is done. The disease moves without announcement, progressing through decades of invisibility before arriving as cirrhosis, liver failure, or cancer — by which point the human and financial costs become nearly unbearable. India has named 2030 as the year it will eliminate viral hepatitis, but that promise rests on a simple, urgent act the country
Liver disease claims double in three years as India grapples with silent hepatitis epidemic
Viral hepatitis claims approximately 1.23 lakh lives annually in India; disease progression to cirrhosis, liver failure, or cancer significantly impacts patient outcomes.
The virus works quietly in the background, scarring tissue for years
Mark
Why does hepatitis stay hidden for so long? What makes it different from other infections?
Mimi
It doesn't trigger the immune response that makes you feel sick. No fever, no fatigue that forces you to bed. The virus just sits there, slowly damaging tissue. By the time your body sends signals—jaundice, pain, exhaustion—years have passed and the liver is already scarred.
Mark
The data shows younger people filing more claims. Why would that be?
Mimi
Possibly because they're more likely to seek treatment once symptoms appear, or they're getting diagnosed through screening. But it could also mean the infection is actually spreading faster in younger populations—through unsafe medical practices, tattoos, piercings. We don't know yet.
Mark
If screening is free, why aren't more people getting tested?
Mimi
Free doesn't mean accessible. You have to know the program exists, know you're at risk, know where to go. In smaller cities, there may be no screening center nearby. And if you feel fine, why would you seek out a test? That's the trap hepatitis sets.
Mark
The cost difference is striking—free screening versus 18 to 35 lakh for a transplant.
Mimi
That's the entire problem in one number. Catch it early, spend nothing, manage it for life. Miss it, and you're looking at catastrophic costs that most families can't absorb. It's not really about medicine at that point. It's about who can afford to survive.
Mark
What would actually change the trajectory?
Mimi
Routine screening as part of standard health checkups. Making it normal, not something you do only if you think you're sick. And education—people need to understand the transmission routes so they can protect themselves. Right now, most people don't even know hepatitis exists until it's too late.
The Pulse
- Liver disease insurance claims have doubled in just three years, with treatment costs rising nearly as steeply — a financial signal that a biological crisis has been quietly compounding beneath public awareness.
- Hepatitis kills approximately 123,000 Indians each year while offering almost no symptoms, meaning most of its 35 million carriers are unknowingly living with a disease that is steadily destroying their liver tissue.
- The burden is shifting toward younger people, women, and residents of smaller Tier II and III cities, where healthcare infrastructure and screening access are often thinner — widening the gap between where the disease spreads and where care can reach.
- A liver transplant costs between 18 and 35 lakh rupees privately, a sum that can erase a family's financial life, even as free government screening programs go largely unused because most people never know to seek them.
- Hepatitis C is curable and hepatitis B is manageable — making early detection not merely helpful but potentially life-saving — yet the window for intervention closes quietly, without warning, as the disease advances.
Across India, a silent epidemic is writing itself into insurance ledgers: liver disease claims have doubled in three years, tracing the quiet devastation of viral hepatitis in a population of 35 million carriers who often feel nothing until the damage is done. The disease moves without announcement, progressing through decades of invisibility before arriving as cirrhosis, liver failure, or cancer — by which point the human and financial costs become nearly unbearable. India has named 2030 as the year it will eliminate viral hepatitis, but that promise rests on a simple, urgent act the country has yet to make routine: looking for the disease before it announces itself.
The warning came not from a hospital ward or a public health announcement, but from insurance data. Over three years, liver disease claims filed with Care Health Insurance have doubled, and treatment costs have climbed nearly as fast. The numbers describe something larger than a statistical trend — they trace the outline of a disease moving through India's population largely unseen.
India carries one of the world's heaviest burdens of viral hepatitis. Roughly 29 million people live with hepatitis B; another 5.5 million carry hepatitis C. Together, they form a population of 35 million chronic carriers, most of whom feel nothing. The virus works in silence, scarring liver tissue over years or decades, progressing toward cirrhosis, liver failure, or cancer without ever announcing itself through obvious symptoms. By the time someone seeks care, the disease has often reached a stage where treatment is both harder and far more expensive. Each year, approximately 123,000 Indians die from viral hepatitis — a toll that rivals better-known diseases but receives a fraction of the attention.
The insurance data reveals that the disease is not spreading evenly. Claims among younger people are growing 5 to 10 percent annually. In Tier II and III cities — smaller urban centers with less healthcare infrastructure — the rise is steeper, between 10 and 15 percent each year. Women are filing claims at rates 10 percent higher year over year. The geography and demographics of the crisis are shifting toward populations that may have the least access to screening.
The financial consequences of late detection are severe. The government provides free hepatitis screening through its National Viral Hepatitis Control Programme, but a liver transplant at a private hospital costs between 18 and 35 lakh rupees — a figure that places it beyond the reach of most families, and that is only the beginning of a lifetime of medications and monitoring.
The routes of transmission are well understood: unsafe injections, contaminated blood, unsterilized medical or cosmetic equipment, shared needles or razors. Prevention is possible. Hepatitis B vaccination, including a dose within 24 hours of birth, can prevent infection entirely. Hepatitis C, once contracted, is curable with modern treatment. Hepatitis B cannot be cured but can be managed, allowing people to live full lives if the disease is caught early.
India has committed to eliminating viral hepatitis by 2030. Whether that goal is reached depends on what happens now — whether screening becomes routine before symptoms appear, whether people at risk are tested before damage accumulates. The insurance data is both a warning and a map, pointing precisely to where intervention must go.
The numbers arrived quietly in the insurance data, but they told a story that should have alarmed anyone paying attention. Over the past three years, liver disease claims filed with Care Health Insurance have doubled. Treatment costs have nearly kept pace, climbing just as steeply. The pattern points to something larger than a statistical blip—it suggests a disease spreading through India's population largely unnoticed, detected only when it has already done serious damage.
India carries an enormous burden of viral hepatitis that most people never think about until it arrives at their door. Roughly 29 million people in the country live with hepatitis B. Another 5.5 million carry hepatitis C. Combined, that is 35 million individuals walking around with a chronic infection that may never announce itself through obvious symptoms. Every year, viral hepatitis claims approximately 123,000 lives in India—a toll that rivals many better-known diseases but receives a fraction of the public attention.
What makes this crisis particularly insidious is its silence. Hepatitis does not announce itself. A person can carry the infection for years, even decades, without feeling sick, without noticing anything wrong. The virus works quietly in the background, scarring liver tissue, destroying cells, progressing toward cirrhosis or liver failure or cancer. By the time someone finally seeks medical attention—often because symptoms have become impossible to ignore—the disease has frequently advanced to a stage where treatment becomes far more difficult and far more expensive.
The insurance data reveals something else worth noting: the disease is not hitting all populations equally. Claims among younger people have grown by 5 to 10 percent each year. In smaller cities—the Tier II and Tier III urban centers that ring India's major metros—claims have risen even faster, by 10 to 15 percent annually. Women are filing claims at rates 10 percent higher year over year. The profile of who is getting sick is shifting, spreading into demographics and geographies that may have less access to healthcare infrastructure or screening programs.
The financial cliff appears once the disease reaches an advanced stage. The government offers hepatitis screening for free through its National Viral Hepatitis Control Programme. But a liver transplant at a private hospital costs between 18 and 35 lakh rupees—a sum that places it far beyond the reach of most Indians. After transplant comes a lifetime of medications and monitoring, an endless stream of expenses that can bankrupt families or force impossible choices about what other needs go unmet.
Hepatitis B and C spread through specific routes: unsafe injections, contaminated blood transfusions, medical procedures conducted without proper precautions, the sharing of needles or razors. Dental work, tattoos, and piercings can transmit the virus if done without sterile equipment. Hepatitis A and E, different strains with different transmission patterns, become more common during monsoon season when water and food safety deteriorate. The routes of transmission are well understood. Prevention is possible.
The response from health authorities has centered on early detection. Screening should happen before symptoms appear, before damage accumulates. Hepatitis B vaccination, including a dose given within 24 hours of birth, can prevent infection entirely. Hepatitis C, once contracted, is curable in most cases with modern treatment. Hepatitis B cannot be cured but can be managed effectively with ongoing medical care, allowing people to live normal lifespans without progression to liver failure.
India has set a target: eliminate viral hepatitis by 2030. That goal depends entirely on what happens in the next few years. If screening remains rare, if people continue to discover their infection only when the disease has advanced, the numbers will keep climbing. If screening becomes routine, if people at risk get tested before symptoms appear, if treatment begins early, the trajectory could change. The insurance data is a warning. It is also a map showing exactly where intervention needs to happen.
Notable Quotes
Hepatitis often remains undetected for years and may only be diagnosed after progressing to cirrhosis, liver failure or liver cancer— Care Health Insurance
Hepatitis C is curable in most cases; hepatitis B can be effectively managed through ongoing medical care— Care Health Insurance
Want the full story?
Read the original at BW Healthcare World ↗
Health & Medicine